Bitterroot Bio Launches Out Of Stealth With $145 Million Series A Financing To Develop Transformative Medicines In Cardio-Immunology

Media coverage

• Title	Bitterroot Bio Launches Out Of Stealth With $145 Million Series A Financing To Develop Transformative Medicines In Cardio-Immunology
  Media name/outlet	MENAFN -Press Releases (English)
  Country/Territory	Jordan
  Date	6/7/23
  Persons	Carol Martin